Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 281 contracts
Samples: Securities Purchase Agreement (Propanc Health Group Corp), Securities Purchase Agreement (Rich Cigars Inc), Securities Purchase Agreement (Mitesco, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 214 contracts
Samples: Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Ecosciences, Inc.), Securities Purchase Agreement (Good Hemp, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 201 contracts
Samples: Securities Purchase Agreement (Growlife, Inc.), Securities Purchase Agreement (Healthcare Integrated Technologies Inc.), Securities Purchase Agreement (Arch Therapeutics, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission”.
Appears in 53 contracts
Samples: Securities Purchase Agreement (TPT Global Tech, Inc.), Securities Purchase Agreement (Pharmagreen Biotech Inc.), Securities Purchase Agreement (Biolargo, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 12 contracts
Samples: Securities Purchase Agreement (Tribal Rides International Corp.), Securities Purchase Agreement (Stealth Technologies, Inc.), Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities 1933 Act as amended on the basis of being a "“bad actor" ” as that term is established defined in the September 19, 2013 Small Entity Compliance Guide published by Rule 506(d)(4) under the Securities and Exchange CommissionSEC 1933 Act.
Appears in 9 contracts
Samples: Securities Purchase Agreement (Resonate Blends, Inc.), Securities Purchase Agreement (Sollensys Corp.), Securities Purchase Agreement (Galaxy Next Generation, Inc.)
Bad Actor. No officer or director of the Company Borrower would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 3 contracts
Samples: Securities Purchase Agreement (SMX (Security Matters) Public LTD Co), Securities Purchase Agreement (ETAO International Co., Ltd.), Securities Purchase Agreement (Bruush Oral Care Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities 1933 Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Clubhouse Media Group, Inc.), Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (Clubhouse Media Group, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.. PW
Appears in 2 contracts
Samples: Securities Purchase Agreement (Pharmagreen Biotech Inc.), Securities Purchase Agreement (Pharmagreen Biotech Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities 1933 Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 2 contracts
Samples: Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (C-Bond Systems, Inc)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 2013, Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Smart Decision, Inc.), Securities Purchase Agreement (Smart Decision, Inc.)
Bad Actor. No To the Company’s knowledge, no officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Guided Therapeutics Inc), Securities Purchase Agreement (Guided Therapeutics Inc)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) 506 of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Friendable, Inc.), Securities Purchase Agreement (Friendable, Inc.)
Bad Actor. No officer or director of the Company Buyer would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 1 contract
Samples: Securities Purchase Agreement (Inception Mining Inc.)
Bad Actor. No officer or director of the Company would be is disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange CommissionSEC.
Appears in 1 contract
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d506( d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Samples: Securities Purchase Agreement (Guided Therapeutics Inc)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September December 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Samples: Securities Purchase Agreement (Endonovo Therapeutics, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ” as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Samples: Securities Purchase Agreement (Endonovo Therapeutics, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, March 30 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Samples: Securities Purchase Agreement (Airborne Wireless Network)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, January 5 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Samples: Securities Purchase Agreement (Airborne Wireless Network)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "“bad actor" ’ as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.
Appears in 1 contract
Samples: Securities Purchase Agreement (Alkame Holdings, Inc.)
